MRI shows residual breast cancer disease better than other modalities

November 30, 2008 DiagnosticImaging.com. MRI shows residual breast cancer disease better than other modalities By Rebekah Moan Preliminary results from American College of Radiology Imaging Network Trial 6657 show that MRI estimates residual breast cancer disease area better than clinical exams or mammography. The study is a part of the national I-SPY collaborative trial of imaging and biomarkers for monitoring and guiding preoperative treatment for women with breast cancer.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC